Imagen de Portada
Código QR

Magnetic-resonance-guided percutaneous laser ablation of uterine fibroids.

Percutaneous laser ablation of uterine fibroids with magnetic resonance thermal monitoring causes shrinkage of treated areas by 37.5% 3 months later. This technique may provide an alternative to open surgery.

Publicado en:Lancet Vol. 354; no. 9195; pp. 2049 - 2051
Autores principales: Law, P., Gedroyc, W.M.W., Regan, L., Gedroyc, W M
Formato: research Journal Article
Publicado: Lancet 12/11/1999
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=2585333&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 2585333
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        01406736
        LAN
      jtl: Lancet
      issn: 01406736
      maglogo: N
    pubinfo:
      dt: 12/11/1999
      vid: 354
      iid: 9195
      pid: 1297
      pub: Lancet
      place: Philadelphia, Pennsylvania
    artinfo:
      ui:
        2585333
        2585333
        NLM10636374
        2585333
        10.1016/S0140-6736(99)04958-2
        NLM10636374
        2585333
      ppf: 2049
      ppct: 2
      formats:
        fmt:
          @attributes:
            type: P
      tig:
        atl: Magnetic-resonance-guided percutaneous laser ablation of uterine fibroids.
      aug:
        au:
          Law, P.
          Gedroyc, W.M.W.
          Regan, L.
          Gedroyc, W M
      sug:
        subj:
          Uterine Neoplasms Surgery
          Magnetic Resonance Imaging Equipment and Supplies
          Leiomyoma Surgery
          Laser Therapy Equipment and Supplies
          Endoscopy
          Treatment Outcomes
          Leiomyoma Diagnosis
          Uterus Surgery
          Middle Age
          Female
          Uterine Neoplasms Diagnosis
          Uterus Pathology
          Adult
          Minimally Invasive Procedures
          Equipment Design
          Human
          Validation Studies
          Comparative Studies
          Evaluation Research
          Multicenter Studies
          Middle Aged: 45-64 years
          Adult: 19-44 years
          Female
      ab: Percutaneous laser ablation of uterine fibroids with magnetic resonance thermal monitoring causes shrinkage of treated areas by 37.5% 3 months later. This technique may provide an alternative to open surgery.
      pubtype: Academic Journal
      doctype:
        research
        Journal Article
      ougenre: Unknown
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N